A new type of covid vaccine which can be snorted or taken as a pill has passed animal trials in Basel.
The University of Basel says the vaccine is based on a modified coronavirus that will trigger an immune response, but won’t multiply in the body.
It’s been developed with the company RocketVax.
It can also be quickly adapted to account for new variants and it’s easier to store.
Human trials are the next stage.
Swiss Post announce job cuts
Swiss Post will eliminate up to 110 positions in 2027, blaming shrinking letter volumes and fewer over-the-counter transactions
Autumn arrives in Switzerland
The heatwave that has gripped Switzerland since May finally breaks tomorrow
Driver warning in Vaud
Drivers in western Vaud face four nights of disruption on the A1 next week.
Mixed results in school classrooms
Swiss 15-year-olds still rank among the world's best in maths and science, but their performance in reading and maths is sliding
Good news for household bills
Swiss households will pay a little less for electricity next year
Fuel reserves now in use
Switzerland is dipping into its emergency fuel reserves for the first time this year to keep petrol and diesel flowing
